ANI Pharmaceuticals (ANIP) PT Raised to $114 at Guggenheim
Tweet Send to a Friend
(Updated - September 8, 2025 7:23 AM EDT)
Guggenheim analyst Vamil Divan raised the price target on ANI Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Vamil Divan raised the price target on ANI Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
